The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination

Earlier studies showed that BCG vaccination improves antibody responses of subsequent vaccinations. Similarly, in older volunteers we found an increased IgG receptor-binding domain (RBD) concentration after SARS-CoV-2 infection if they were recently vaccinated with BCG. This study aims to assess the effect of BCG on the serum antibody concentrations induced by COVID-19 vaccination in a population of adults older than 60 years. Serum was collected from 1,555 participants of the BCG-CORONA-ELDERLY trial a year after BCG or placebo, and we analyzed the anti-SARS-CoV-2 antibody concentrations using a fluorescent-microsphere-based multiplex immunoassay. Individuals who received the full primary COVID-19 vaccination series before serum collection and did not test positive for SARS-CoV-2 between inclusion and serum collection were included in analyses (n = 945). We found that BCG vaccination before first COVID-19 vaccine (median 347 days [IQR 329–359]) did not significantly impact the IgG RBD concentration after COVID-19 vaccination in an older European population. [Display omitted] •BCG vaccine prior to COVID-19 vaccines does not increase anti-SARS-CoV-2 antibodies•Sex differences in antibody concentration are still present in older adults•Interval between BCG and subsequent COVID-19 vaccination may play a role in its effect Health sciences; Medical science; Microbiology; Virology